Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Dexasone
Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalP4BB (68)
Dexasone
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (68)
Dexasone
Non-Small Cell Lung Carcinoma
Rigshospitalet, DenmarkP4BB (68)
Dexasone
Sciatica
University of MiamiP4BB (68)
Dexmedetomidine
Breast Cancer
Tianjin Medical University Cancer Institute and HospitalP4BB (68)
Dexmedetomidine
Epilepsy
China International Neuroscience InstitutionP4BB (68)
Dexmedetomidine
Morbid Obesity
Cairo UniversityP4BB (68)
Duloxetine
Osteoarthritis
The Catholic University of KoreaP4BB (68)
Enzalutamide
Metastatic Prostate Carcinoma
AstraZenecaP4BB (68)
Epirubicin
Triple-Negative Breast Carcinoma
M.D. Anderson Cancer CenterP4BB (68)
Escitalopram
Dementia
Ohio State UniversityP4BB (68)
Eukystol
Schizophrenia
Centre Hospitalier St AnneP4BB (68)
Exemestane
Invasive Breast Carcinoma
University of California, San FranciscoP4BB (68)
Febuxostat
Gout
Haiphong University of Medicine and PharmacyP4BB (68)
Fentanyl
Migraine Disorder
Washington University School of MedicineP4BB (68)
Fentanyl
Post-Operative Pain, Non-Human Animal
IVO JURISICP4BB (68)
Fludarabine
Acute Myeloid Leukemia
City of Hope Medical CenterP4BB (68)
(±)-Ftc
HIV Infectious Disease
José Antonio Mata MarínP4BB (68)
Fulvestrant
Hormone Receptor-Positive Breast Cancer
BeOne MedicinesP4BB (68)
Ginkgo Biloba
Cognitive Disorder
Dr. Willmar Schwabe GmbH & Co. KGP4BB (68)
Ginkgo Biloba Extract
Cognitive Disorder
Hanyang UniversityP4BB (68)
Hydrochlorothiazide
Abdominal Obesity-Metabolic Syndrome
UMC UtrechtP4BB (68)
Hydrocortisone
Acute Lymphoblastic Leukemia
Children's Oncology GroupP4BB (68)
Ibrutinib
Lymphoid Leukemia
Loxo Oncology, Inc.P4BB (68)
Ibrutinib
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLCP4BB (68)
Showing 1351 to 1375 of 42,301 assets
PreviousPage 55 of 1693Next